Literature DB >> 16927470

Reversibility of an "apparent" infarct on dynamic perfusion CT after lytic therapy: comment regarding cerebral blood flow and blood volume thresholds.

A McKinney, C L Truwit, S Kieffer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16927470      PMCID： PMC7977508     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN： 0195-6108            Impact factor:   3.825


× No keyword cloud information.
  11 in total

1.  Frequency and clinical context of decreased apparent diffusion coefficient reversal in the human brain.

Authors:  P E Grant; J He; E F Halpern; O Wu; P W Schaefer; L H Schwamm; R F Budzik; A G Sorensen; W J Koroshetz; R G Gonzalez
Journal:  Radiology       Date:  2001-10       Impact factor: 11.105

2.  First-pass quantitative CT perfusion identifies thresholds for salvageable penumbra in acute stroke patients treated with intra-arterial therapy.

Authors:  P W Schaefer; L Roccatagliata; C Ledezma; B Hoh; L H Schwamm; W Koroshetz; R G Gonzalez; M H Lev
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

3.  Accuracy of dynamic perfusion CT with deconvolution in detecting acute hemispheric stroke.

Authors:  Max Wintermark; Nancy J Fischbein; Wade S Smith; Nerissa U Ko; Marcel Quist; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005-01       Impact factor: 3.825

4.  Dynamic CT perfusion imaging of acute stroke.

Authors:  T E Mayer; G F Hamann; J Baranczyk; B Rosengarten; E Klotz; M Wiesmann; U Missler; G Schulte-Altedorneburg; H J Brueckmann
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

5.  CT perfusion parameter values in regions of diffusion abnormalities.

Authors:  Marcello Galvez; Gerald E York; James D Eastwood
Journal:  AJNR Am J Neuroradiol       Date:  2004-08       Impact factor: 3.825

6.  Correlation of early dynamic CT perfusion imaging with whole-brain MR diffusion and perfusion imaging in acute hemispheric stroke.

Authors:  James D Eastwood; Michael H Lev; Max Wintermark; Clemens Fitzek; Daniel P Barboriak; David M Delong; Ting-Yim Lee; Tarek Azhari; Michael Herzau; Vani R Chilukuri; James M Provenzale
Journal:  AJNR Am J Neuroradiol       Date:  2003-10       Impact factor: 3.825

7.  Late secondary ischemic injury in patients receiving intraarterial thrombolysis.

Authors:  Chelsea S Kidwell; Jeffrey L Saver; Sidney Starkman; Gary Duckwiler; Reza Jahan; Paul Vespa; J Pablo Villablanca; David S Liebeskind; Y Pierre Gobin; Fernando Vinuela; Jeffry R Alger
Journal:  Ann Neurol       Date:  2002-12       Impact factor: 10.422

8.  Characterization and evolution of diffusion MR imaging abnormalities in stroke patients undergoing intra-arterial thrombolysis.

Authors:  Pamela W Schaefer; Alvand Hassankhani; Christopher Putman; A Gregory Sorensen; Lee Schwamm; Walter Koroshetz; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

9.  Tissue at risk of infarction rescued by early reperfusion: a positron emission tomography study in systemic recombinant tissue plasminogen activator thrombolysis of acute stroke.

Authors:  W D Heiss; M Grond; A Thiel; H M von Stockhausen; J Rudolf; M Ghaemi; J Löttgen; C Stenzel; G Pawlik
Journal:  J Cereb Blood Flow Metab       Date:  1998-12       Impact factor: 6.200

10.  Comparison of admission perfusion computed tomography and qualitative diffusion- and perfusion-weighted magnetic resonance imaging in acute stroke patients.

Authors:  M Wintermark; M Reichhart; O Cuisenaire; P Maeder; J-P Thiran; P Schnyder; J Bogousslavsky; R Meuli
Journal:  Stroke       Date:  2002-08       Impact factor: 7.914
View more
  1 in total

1.  CT perfusion identifies increased salvage of tissue in patients receiving intravenous recombinant tissue plasminogen activator within 3 hours of stroke onset.

Authors:  H M Silvennoinen; L M Hamberg; P J Lindsberg; L Valanne; G J Hunter
Journal:  AJNR Am J Neuroradiol       Date:  2008-04-10       Impact factor: 3.825
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.